CP
Highly rated in
10
conditions

Dr. Crystal M. Proud

Health And Surgery Center At Oyster Point
Newport News, VA
Highly rated in
10
conditions
Specialties:Pediatrics | Neurology
Experience:14 Years
Clinical Trials:Currently Recruiting for 6 Trials
Accepts:New PatientsMedicare
Highly rated in
10
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Crystal M. Proud's experience treating your condition:
About Dr. Crystal M. Proud

Crystal Proud is a Pediatrics specialist and a Neurologist in Newport News, Virginia. Proud has been practicing medicine for over 14 years and is highly rated in 10 conditions, according to our data. Her top areas of expertise are Spinal Muscular Atrophy Type 2, X-Linked Infantile Spinal Muscular Atrophy, Spinal Muscular Atrophy with Arthrogryposis, and Spinal Muscular Atrophy (SMA). She is licensed to treat patients in California and Virginia. Proud is currently accepting new patients.

Her clinical research consists of co-authoring 9 peer reviewed articles and participating in 15 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Crystal M. Proud it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Crystal M. Proud accepts the following insurance:

  •  UnitedHealthcare
  •  HealthKeepers
Call to see if your plan is accepted.
Locations
11783 Rock Landing Dr, Newport News, VA 23606
Other Locations
850 Southampton Ave, Fl 3, Norfolk, VA 23510
500 Discovery Dr, Chesapeake, VA 23320
5834 Harbour View Blvd, Suffolk, VA 23435
7021 Harbor View Blvd, Suffolk, VA 23435
825 Fairfax Ave, Norfolk, VA 23507
2021 Concert Dr, Virginia Beach, VA 23456
Background & Education
Graduate Institution
Eastern Virginia Medical School, 2009
Specialties
Pediatrics
Neurology
Licenses
Neurology with Special Qualifications in Neurology in CA
Hospital Affiliations
Pleasant Valley Medical Center
Childrens Hospital Of The Kings Daughters
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials
Journey: A Global, Multicenter, Longitudinal Study of the Natural History of Subjects With Limb Girdle Muscular Dystrophy (LGMD) Type 2E (LGMD2E/R4), Type 2D (LGMD2D/R3), and Type 2C (LGMD2C/R5)
Enrollment Status: Recruiting
Publish Date: August 25, 2022
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Recruiting
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drugs: SRP-4045 Exon 45-Skipping TreatmentSRP-4053 Exon 53-Skipping Treatment
Study Phase: Phase 3
A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Enrollment Status: Recruiting
Publish Date: June 01, 2022
Intervention Type: Drug, Other
A Phase 3b Study to Evaluate Higher Dose Nusinersen (BIIB058) in Patients With Spinal Muscular Atrophy Previously Treated With Risdiplam
Enrollment Status: Recruiting
Publish Date: October 24, 2022
Intervention Type: Drug
Study Drug: Nusinersen
Study Phase: Phase 3
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Tideglusib Versus Placebo for the Treatment of Children and Adolescents With Congenital Myotonic Dystrophy (REACH CDM)
Enrollment Status: Recruiting
Publish Date: August 15, 2022
Intervention Type: Drug
Study Drug: Tideglusib
Study Phase: Phase 2/Phase 3
A Randomized, Sham-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Intrathecal OAV101 in Type 2 Spinal Muscular Atrophy (SMA) Patients Who Are ≥ 2 to < 18 Years of Age, Treatment Naive, Sitting, and Never Ambulatory
Enrollment Status: Recruiting
Publish Date: November 03, 2022
Intervention Type: Genetic, Procedure
Study Phase: Phase 3
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
Enrollment Status: Completed
Publish Date: September 07, 2022
Intervention Type: Biological
Study Drug: Onasemnogene Abeparvovec-Xioi
Study Phase: Phase 3
An Open-Label, Systemic Gene Delivery Study Using Commercial Process Material to Evaluate the Safety of and Expression From SRP-9001 in Subjects With Duchenne Muscular Dystrophy (ENDEAVOR)
Enrollment Status: Enrolling by invitation
Publish Date: September 30, 2022
Intervention Type: Genetic
Study Phase: Phase 1
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Active, not recruiting
Publish Date: March 31, 2022
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Active, not recruiting
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Phase 2 Clinical Pharmacology Study to Assess Dystrophin Levels in Subjects With nmDMD Before and After Treatment With Ataluren
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)
Enrollment Status: Active, not recruiting
Publish Date: November 15, 2022
Intervention Type: Genetic
Study Phase: Phase 3
A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA® (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
Enrollment Status: Active, not recruiting
Publish Date: September 21, 2022
Intervention Type: Other
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Active, not recruiting
Publish Date: August 22, 2022
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
View 9 Less Clinical Trials -
9 Total Publications
Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review Study.
Journal: Journal of neuromuscular diseases
Published: August 29, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
KL
Dr. Kermit A. Lloyd
Neurology
Highly rated in
42
conditions
Neurology

Riverside Health System

Riverside Partners In Women's Health - Warwick

12200 Warwick Blvd, 
Newport News, VA 
 2.0 mi

Kermit Lloyd is a Neurologist in Newport News, Virginia. Lloyd has been practicing medicine for over 34 years and is highly rated in 42 conditions, according to our data. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Migraine, and Autosomal Dominant Partial Epilepsy with Auditory Features. He is licensed to treat patients in Virginia. Lloyd is currently accepting new patients.

JB
Dr. Jonathan T. Butler
Neurology
Highly rated in
34
conditions
Neurology

Riverside Health System

Riverside Physician Services Inc

Newport News, VA 
 2.0 mi

Jonathan Butler is a Neurologist in Newport News, Virginia. Butler has been practicing medicine for over 12 years and is highly rated in 34 conditions, according to our data. His top areas of expertise are Essential Tremor, Parkinson's Disease, Memory Loss, Secondary Parkinsonism, and Deep Brain Stimulation. He is licensed to treat patients in Virginia. Butler is currently accepting new patients.

KB
Dr. Kamel Ben Othmane
Neurology
Highly rated in
29
conditions
Neurology

Riverside Health System

Riverside Neurology Specialists - Newport News

12200 Warwick Blvd, 
Newport News, VA 
 2.0 mi

Kamel Ben Othmane is a Neurologist in Newport News, Virginia. Ben Othmane has been practicing medicine for over 33 years and is highly rated in 29 conditions, according to our data. His top areas of expertise are Migraine, Memory Loss, Migraine with Brainstem Aura, and Epilepsy. He is licensed to treat patients in Virginia. Ben Othmane is currently accepting new patients.